John Reed (Jeff Rumans for Endpoints News)
Sanofi's first big trial for top cancer drug ends in setback
One of Sanofi’s top late-stage prospects has failed its first major test in breast cancer, dimming blockbuster hopes even as the French drugmaker doubles down …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
